Roopal Patel

704 total citations · 1 hit paper
18 papers, 205 citations indexed

About

Roopal Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Roopal Patel has authored 18 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Roopal Patel's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Roopal Patel is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Roopal Patel collaborates with scholars based in United States, India and United Kingdom. Roopal Patel's co-authors include Jeremy Adler, Anthony I. Magee, Ingela Parmryd, Harold W. Goforth, Lukasz M. Konopka, Kathleen O’Donnell, Margaret Primeau, Parvez Shirazi, Murali Rao and Bhupendra G. Prajapati and has published in prestigious journals such as Cancer Research, Annals of Oncology and Experimental Cell Research.

In The Last Decade

Roopal Patel

14 papers receiving 198 citations

Hit Papers

Tumor microenvironment: recent advances in understanding ... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roopal Patel United States 8 98 49 47 28 27 18 205
Tabish Hussain United States 11 125 1.3× 53 1.1× 23 0.5× 31 1.1× 9 0.3× 25 287
Wenzheng Yuan China 9 149 1.5× 48 1.0× 21 0.4× 86 3.1× 21 0.8× 11 223
Taylor M. Parker United States 7 102 1.0× 51 1.0× 27 0.6× 63 2.3× 7 0.3× 7 226
Elena Fiorini Italy 7 57 0.6× 61 1.2× 15 0.3× 22 0.8× 140 5.2× 21 300
Maya Chopra United States 11 151 1.5× 57 1.2× 18 0.4× 15 0.5× 51 1.9× 25 406
Ying Yue China 10 98 1.0× 34 0.7× 26 0.6× 43 1.5× 37 1.4× 21 233
Xueying Lyu United States 8 92 0.9× 35 0.7× 15 0.3× 61 2.2× 25 0.9× 21 192
Tanner C. Dalton United States 4 73 0.7× 134 2.7× 13 0.3× 29 1.0× 17 0.6× 5 258
Outi Kuismin Finland 9 118 1.2× 18 0.4× 22 0.5× 40 1.4× 13 0.5× 35 253
Melanie Keil Germany 5 63 0.6× 64 1.3× 26 0.6× 13 0.5× 8 0.3× 6 181

Countries citing papers authored by Roopal Patel

Since Specialization
Citations

This map shows the geographic impact of Roopal Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roopal Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roopal Patel more than expected).

Fields of papers citing papers by Roopal Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roopal Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roopal Patel. The network helps show where Roopal Patel may publish in the future.

Co-authorship network of co-authors of Roopal Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Roopal Patel. A scholar is included among the top collaborators of Roopal Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roopal Patel. Roopal Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Patel, Roopal, et al.. (2025). From current landscape to future horizon in stem cell therapy for tissue regeneration and wound healing: bridging the gap. Zeitschrift für Naturforschung C. 81(1-2). 55–74.
3.
Chorawala, Mehul R., et al.. (2025). Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies. Medical Oncology. 42(4). 117–117. 20 indexed citations breakdown →
4.
Desai, R., et al.. (2025). Harnessing the immune responses: a new frontier in Ewing sarcoma treatment. Medical Oncology. 42(8). 291–291.
5.
Patel, Roopal, et al.. (2025). Therapeutic potential of stem cells in colorectal cancer management: Current trends and future prospects. Developmental Dynamics. 254(12). 1250–1274.
6.
Hong, Min Hee, Alexander I. Spira, Ki Hyeong Lee, et al.. (2023). 1333P A global phase 1b study of ORIC-114, a highly selective, brain penetrant EGFR and HER2 inhibitor, in patients with advanced solid tumors harboring EGFR Exon 20 or HER2 alterations. Annals of Oncology. 34. S769–S769. 5 indexed citations
7.
Price, Elizabeth, Roopal Patel, Irene Scheimberg, et al.. (2021). MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genetics. 42(5). 604–611. 7 indexed citations
8.
Patel, Roopal, et al.. (2020). Determination of the s‐phase formation coefficient of plasma nitrided austenitic steel. Materialwissenschaft und Werkstofftechnik. 52(2). 193–201. 3 indexed citations
9.
Price, Elizabeth, Roopal Patel, Esin Kotiloğlu Karaa, et al.. (2018). Detection and reporting of RB1 promoter hypermethylation in diagnostic screening. Ophthalmic Genetics. 39(4). 526–531. 13 indexed citations
10.
Tao, Jessica J., Wei Ge, Roopal Patel, et al.. (2018). ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib. JCO Precision Oncology. 2(2). 1–8. 28 indexed citations
11.
Ge, Wei, Roopal Patel, C J Walsh, et al.. (2016). Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. European Journal of Cancer. 69. S33–S33. 4 indexed citations
12.
Ge, Wei, Elena Ardini, Roopal Patel, et al.. (2016). Abstract 2136: Entrectinib is effective against the gatekeeper and other emerging resistance mutations in NTRK-, ROS1- and ALK- rearranged cancers. Cancer Research. 76(14_Supplement). 2136–2136. 5 indexed citations
13.
Li, Gang, Seung Tae Kim, Kyoung‐Mee Kim, et al.. (2015). Abstract A173: Potent anti-tumor activity of entrectinib in patient-derived models harboring oncogenic gene rearrangements of NTRKs. Molecular Cancer Therapeutics. 14(12_Supplement_2). A173–A173. 1 indexed citations
14.
Siena, Salvatore, Alexander Drilon, Anna F. Farago, et al.. (2015). 29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements. European Journal of Cancer. 51. S724–S725. 9 indexed citations
15.
Patel, Roopal, et al.. (2012). Applied peritoneal anatomy. Clinical Radiology. 68(5). 509–520. 14 indexed citations
16.
Patel, Roopal. (2011). Applied Peritoneal Anatomy - A Pictorial review.. European Society of Radiology. 1 indexed citations
17.
Goforth, Harold W., Lukasz M. Konopka, Margaret Primeau, et al.. (2004). Quantitative Electroencephalography in Frontotemporal Dementia with Methylphenidate Response: A Case Study. Clinical EEG and Neuroscience. 35(2). 108–111. 37 indexed citations
18.
Parmryd, Ingela, Jeremy Adler, Roopal Patel, & Anthony I. Magee. (2003). Imaging metabolism of phosphatidylinositol 4,5-bisphosphate in t-cell GM1-enriched domains containing Ras proteins☆. Experimental Cell Research. 285(1). 27–38. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026